Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders

Frontiers in Molecular Neuroscience

Volumn 7, Issue FEB, 2014, Pages

  Gross, Christina ^a   Bassell, Gary J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Epilepsy; Neuronal signal transduction; PI3K signaling; Schizophrenia

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHATIDYLINOSITOL KINASE; PROTEIN P110;

AUTISM; BRAIN DISEASE; DNA POLYMORPHISM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME REGULATION; EPILEPSY; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; NERVE FIBER REGENERATION; NONHUMAN; PHENOTYPE; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84894110828     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00012     Document Type: Review

References (96)

1. Acebes, A., Devaud, J. M., Arnes, M., and Ferrus, A. (2012). Central adaptation to odorants depends on PI3K levels in local interneurons of the antennal lobe. J. Neurosci. 32,417-422. doi: 10.1523/JNEUROSCI.2921-11.2012.
2. Acebes, A., Martin-Pena, A., Chevalier, V., and Ferrus, A. (2011). Synapse loss in olfactorylocal interneurons modifies perception. J. Neurosci. 31,2734-2745. doi: 10.1523/JNEUR0SCI.5046-10.2011.
3. Akinleye, A., Avvaru, P., Furqan, M., Song, Y., and Liu, D. (2013). Phosphatidylinos-itol 3-kinase (PI3K) inhibitors as cancer therapeutics. J. Hematol. Oncol. 6, 88. doi: 10.1186/1756-8722-6-88.
4. Angulo, I., Vadas, O., Garcon, F., Banham-Hall, E., Plagnol, V., Leahy, T. R., et al. (2013). Phosphoinositide 3-Kinase deltagene mutation predisposes to respiratory infectionandairwaydamage. Science 342, 866-871. doi: 10.1126/science.1243292.
5. Bi, L., Okabe, I., Bernard, D. J., and Nussbaum, R. L. (2002). Early embryonic lethalityin mice deficient in thep110beta catalytic subunit ofPI 3-kinase. Mamm. Genome 13, 169-172. doi: 10.1007/s00335-001-2123-x
6. Bosco, D., Fava, A., Plastino, M., Montalcini, T., and Pujia, A. (2011). Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis. J. Cell. Mol. Med. 15, 1807-1821. doi: 10.1111/j.1582-4934.2011.01318.x
7. Brennan-Minnella, A. M., Shen, Y., El-Benna, J., and Swanson, R. A. (2013). Phosphoinositide 3-kinase couples NMDA receptors to superoxide release in excitotoxic neuronal death. CellDeath Dis. 4, e580. doi: 10.1038/cddis.2013.111
8. Camps, M., Ruckle, T., Ji, H., Ardissone, V., Rintelen, F., Shaw, J., et al. (2005). Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med. 11, 936-943. doi: 10.1038/nm1284.
9. Chan, C.-B., Liu, X., Ensslin, M. A., Dillehay, D. L., Ormandy, C. J., Sohn, P., et al. (2010). PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. EMBO J. 29, 956-968. doi: 10.1038/emboj.2009.406.
10. Christie, K. J., Webber, C. A., Martinez, J. A., Singh, B., and Zochodne, D. W. (2010). PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons. J. Neurosci. 30, 9306-9315. doi: 10.1523/jneurosci.6271-09.2010.
11. Cuesto, G., Enriquez-Barreto, L., Carames, C., Cantarero, M., Gasull, X., Sandi, C., et al. (2011). Phosphoinositide-3-kinase activation controls synaptogene-sis and spinogenesis in hippocampal neurons. J. Neurosci. 31, 2721-2733. doi: 10.1523/JNEUROSCI.4477-10.2011.
12. Cusco, I., Medrano, A., Gener, B., Vilardell, M., Gallastegui, F., Villa, O., et al. (2009). Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder. Hum. Mol. Genet. 18, 1795-1804. doi: 10.1093/hmg/ddp092.
13. Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y., Mele, A., Fraser, C. E., et al. (2011). FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247-261. doi: 10.1016/j.cell.2011.06.013.
14. Dbouk, H. A., Pang, H., Fiser, A., and Backer, J. M. (2010). A biochemical mechanism for the oncogenic potential of the p110beta catalytic subunit of phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. U.S.A. 107, 19897-19902. doi: 10.1073/pnas.1008739107
15. de la Monte, S. M. (2013). Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art. Expert Opin. Drug Deliv. 10, 1699-1709. doi: 10.1517/17425247.2013.856877.
16. Domin, J., and Waterfield, M. D. (1997). Using structure to define the function of phosphoinositide 3-kinase family members. FEBS Lett. 410, 91-95. doi: 10.1016/S0014-5793(97)00617-0.
17. Eickholt, B. J., Ahmed, A. I., Davies, M., Papakonstanti, E. A., Pearce, W., Starkey, M. L., et al. (2007). Control of axonal growth and regeneration of sensory neurons by the p110§ PI 3-kinase. PLoS ONE 2:e869. doi: 10.1371/journal.pone.00 00869
18. Fayard, E., Xue, G., Parcellier, A., Bozulic, L., and Hemmings, B. A. (2010). Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway. Curr. Top. Microbiol. Immunol. 346, 31-56. doi: 10.1007/82_2010_58.
19. Foukas, L. C., Berenjeno, I. M., Gray, A., Khwaja, A., and Vanhaesebroeck, B. (2010).Activity of any class IA PI3K isoform can sustain cell proliferation and survival. Proc. Natl. Acad. Sci. U.S.A. 107, 11381-11386. doi: 10.1073/pnas.09064 61107
20. Freiherr, J., Hallschmid, M., Frey, W. H. II, Brunner, Y. F., Chapman, C. D., Holscher, C., et al. (2013). Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence. CNS Drugs 27, 505-514. doi: 10.1007/s40263-013-0076-8.
21. Fritsch, R., dekrijger, I., Fritsch, K., George, R., Reason, B., Kumar, MS., et al. (2013). RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms. Cell 153, 1050-1063. doi: 10.1016/j.cell.2013.04.031.
22. Gao, X., Lowry, P. R., Zhou, X., Depry, C., Wei, Z., Wong, G. W., et al. (2011).PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains. Proc. Natl. Acad. Sci. U.S.A. 108, 14509-14514. doi: 10.1073/pnas.1019386108
23. Gross, C., and Bassell, G. J. (2012). Excess protein synthesis in FXS patient lym-phoblastoid cells can be rescued with a p110beta-selective inhibitor. Mol. Med. 18, 336-345. doi: 10.2119/molmed.2011.00363.
24. Gross, C., Nakamoto, M., Yao, X., Chan, C. B., Yim, S. Y., Ye, K., et al. (2010). Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J. Neurosci. 30, 10624-10638. doi: 10.1523/JNEUROSCI.0402-10.2010.
25. Guillermet-Guibert, J., Bjorklof, K., Salpekar, A., Gonella, C., Ramadani, F., Bilancio, A., et al. (2008). The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc. Natl. Acad. Sci. U.S.A. 105, 8292-8297. doi: 10.1073/pnas.0707761105.
26. Gutierrez, A., Sanda, T., Grebliunaite, R., Carracedo, A., Salmena, L., Ahn, Y., et al. (2009). High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood 114, 647-650. doi: 10.1182/blood-2009-02-r)(\c,ir)r)
27. Hawkins, P. T., Anderson, K. E., Davidson, K., and Stephens, L. R. (2006). Signalling through Class I PI3Ks in mammalian cells. Biochem. Soc. Trans. 34, 647-662. doi: 10.1042/BST0340647.
28. Hoeffer, C.A., and Klann, E. (2010). mTORsignaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67-75. doi: 10.1016/j.tins.2009.11.003.
29. Huang, C.-C., Lee, C.-C., and Hsu, K.-S. (2004). An investigation into signal transduction mechanisms involved in insulin-induced long-term depression in the CA1 region of the hippocampus. J. Neurochem. 89, 217-231. doi: 10.1111/j.1471-4159.2003.02307.x
30. Huang, C.-C., You, J.-L., Lee, C.-C., and Hsu, K.-S. (2003). Insulin induces a novel form of postsynaptic mossy fiber long-term depression in the hippocampus. Mol. Cell. Neurosci. 24, 831-841. doi: 10.1016/S1044-7431(03)00238-0.
31. Inoki, K., Li, Y., Zhu, T., Wu, J., and Guan, K.-L. (2002). TSC2 is phosphorylated and inhibited byAkt and suppresses mTORsignalling. Nat. Cell Biol. 4, 648-657. doi: 10.1038/ncb839
32. International Molecular Genetic Study of Autism Consortium. (2001). Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Hum. Mol. Genet. 10,973-982.doi: 10.1093/hmg/10.9.973.
33. Jaworski, J., Spangler, S., Seeburg, D. P., Hoogenraad, C. C., and Sheng, M. (2005). Control of dendritic arborization by the phosphoinositide-37-kinase-Akt-mammalian target of rapamycin pathway. J. Neurosci. 25, 11300-11312. doi: 10.1523/JNEUROSCI.2270-05.2005.
34. Jia, S., Liu, Z., Zhang, S., Liu, P., Zhang, L., Lee, S. H., et al. (2008). Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 454, 776-779. doi: 10.1038/nature07091.
35. Jou, S.-T., Carpino, N., Takahashi, Y., Piekorz, R., Chao, J.-R., Carpino, N., et al. (2002). Essential, nonredundant role for the phosphoinositide 3-kinase p1105 in signaling by the B-cell receptor complex. Mol. Cell. Biol. 22, 8580-8591. doi: 10.1128/mcb.22.24.8580-8591.2002.
36. Kalkman, H. O. (2006). The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. Pharmacol. Ther. 110, 117-134. doi: 10.1016/j.pharmthera.2005.10.014.
37. Kang, S., Denley, A., Vanhaesebroeck, B., and Vogt, P. K. (2006). Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. U.S.A. 103, 1289-1294. doi: 10.1073/pnas.0510772103.
38. Karam, C. S., Ballon, J. S., Bivens, N. M., Freyberg, Z., Girgis, R. R., Lizardi-Ortiz, J. E., et al. (2010). Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends Pharmacol. Sci. 31, 381-390. doi: 10.1016/j.tips.2010.05.004.
39. Kim, J. I., Lee, H. R., Sim, S. E., Baek, J., Yu, N. K., Choi, J. H., et al. (2011). PI3Kgamma is required for NMDA receptor-dependent long-term depression and behavioral flexibility. Nat. Neurosci. 14, 1447-1454. doi: 10.1038/nn.2937.
40. Kim, T. H., Petrou, S., and Reid, C. A. (2013). Low glycaemic index diet reduces seizure susceptibilityinasyndrome-specific mouse model of generalized epilepsy. Epilepsy Res. doi: 10.1016/j.eplepsyres.2013.10.014.
41. Knight, Z. A., Gonzalez, B., Feldman, M. E., Zunder, E. R., Goldenberg, D. D., Williams, O., et al. (2006). A pharmacological map of the PI3-K family defines a role for p110 ± in insulin signaling. Cell 125, 733-747. doi: 10.1016/j.cell.2006.03.035.
42. Koren, S., and Bentires-Alj, M. (2013). Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammarytumors. FEBS J. 280,2758-2765. doi: 10.1111/febs.12175
43. Kratz, C. P., Emerling, B. M., Bonifas, J., Wang, W., Green, E. D., Beau, M. M. L., et al. (2002). Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor. Blood 99, 372-374. doi: 10.1182/blood.V99.1.372.
44. Krueger, D. A., Wilfong, A. A., Holland-Bouley, K., Anderson, A. E., Agricola, K., Tudor, C., et al. (2013). Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann. Neurol. 74, 679-687. doi: 10.1002/ana.23960.
45. Kurosu, H., and Katada, T. (2001). Association of phosphatidylinositol 3-kinase composed of p110beta-catalytic and p85-regulatory subunits with the small GTPase Rab5. J. Biochem. 130, 73-78. doi: 10.1093/oxfordjour-nals.jbchem.a002964.
46. Kurosu, H., Maehama, T., Okada, T., Yamamoto, T., Hoshino, S., Fukui, Y., et al. (1997). Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide. J. Biol. Chem. 272, 24252-24256. doi: 10.1074/jbc.272.39.24252
47. Law, A. J., Kleinman, J. E., Weinberger, D. R., and Weickert, C. S. (2007). Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum. Mol. Genet. 16, 129-141. doi: 10.1093/hmg/ddl449.
48. Law, A. J., Lipska, B. K., Weickert, C. S., Hyde, T. M., Straub, R. E., Hashimoto, R., et al. (2006). Neuregulin 1 transcripts are differentiallyexpressedin schizophrenia and regulated by 57. SNPs associated with the disease. Proc. Natl. Acad. Sci. U.S.A. 103, 6747-6752. doi: 10.1073/pnas.0602002103.
49. Law, A. J., Wang, Y., Sei, Y., O'Donnell, P., Piantadosi, P., Papaleo, F., et al. (2012). Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110delta inhibition as a potential therapeutic strategy. Proc. Natl. Acad. Sci. U.S.A. 109,12165-12170. doi: 10.1073/pnas.1206118109.
50. Lee, C.-C., Huang, C.-C., and Hsu, K.-S. (2011). Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways. Neuropharmacology 61, 867-879. doi: 10.1016/j.neuropharm.2011.06.003.
51. Lee, J. H., Huynh, M., Silhavy, J. L., Kim, S., Dixon-Salazar, T., Heiberg, A., et al. (2012). De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat. Genet. 44, 941-945. doi: 10.1038/ng.2329
52. Lemmon, M. A. (2007). Pleckstrin homology (PH) domains and phosphoinositides. Biochem. Soc. Symp. 81-93. doi: 10.1042/BSS0740081.
53. Levitt, P., and Campbell, D. B. (2009). The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J. Clin. Invest. 119,747-754. doi: 10.1172/JCI37934.
54. Liu, K., Lu, Y., Lee, J. K., Samara, R., Willenberg, R., Sears-Kraxberger, I., et al. (2010).PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 13,1075-1081. doi: 10.1038/nn.2603
55. Man, H.-Y., Wang, Q., Lu, W.-Y., Ju, W., Ahmadian, G., Liu, L., et al. (2003). Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons. Neuron 38, 611-624. doi: 10.1016/S0896-6273(03)00228-9.
56. Mitome-Mishima, Y., Miyamoto, N., Tanaka, R., Oishi, H., Arai, H., Hattori, N., et al. (2013). Differences in phosphodiesterase 3A and 3B expression after ischemic insult. Neurosci. Res. 75, 340-348. doi: 10.1016/j.neures.2013.02.006.
57. Neddens, J., Fish, K. N., Tricoire, L., Vullhorst, D., Shamir, A., Chung, W., et al. (2011).Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia. Biol. Psychiatry 70, 636-645. doi: 10.1016/j.biopsych.2011.04.016
58. Norton, N., Moskvina, V., Morris, D. W., Bray, N. J., Zammit, S., Williams, N. M., et al. (2006). Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 141B, 96-101. doi: 10.1002/ajmg.b.30236.
59. Okkenhaug, K. (2013). Signaling by the phosphoinositide 3-kinase family in immune cells. Annu. Rev. Immunol. 31, 675-704. doi: 10.1146/annurev-immunol-032712-095946.
60. Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., et al. (2002). Impaired B and T cell antigen receptor signaling inp110delta PI 3-kinase mutant mice. Science 297, 1031-1034. doi: 10.1126/science.1073560.
61. Opazo, P., Watabe, A. M., Grant, S. G., and O'Dell, T. J. (2003). Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms. J. Neurosci. 23, 3679-3688.
62. Ostapchenko, V. G., Beraldo, F. H., Guimarâes, A. L. S., Mishra, S., Guzman, M., Fan, J., et al. (2013). Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease. J. Neurochem. 127,415-425. doi: 10.1111/jnc.12296.
63. Oudit, G. Y., and Kassiri, Z. (2007). Role of PI3 kinase gamma in excitation-contractioncouplingandheartdisease. Cardiovasc. Hematol. Disord. DrugTargets 7, 295-304. doi: 10.2174/187152907782793545.
64. Park, K. K., Liu, K., Hu, Y., Smith, P. D., Wang, C., Cai, B., et al. (2008). Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTORpathway. Science 322,963-966. doi: 10.1126/science.1161566.
65. Patrucco, E., Notte, A., Barberis, L., Selvetella, G., Maffei, A., Brancaccio, M., et al. (2004). PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 118, 375-387. doi: 10.1016/j.cell.2004.07.017.
66. Polak, R., and Buitenhuis, M. (2012). The PI3K/PKB signaling module as keyregu-lator of hematopoiesis: implications for therapeutic strategies in leukemia. Blood 119, 911-923. doi: 10.1182/blood-2011-07-366203
67. Reinhardt, R. R., and Bondy, C. A. (1996). Differential cellular pattern of gene expression for two distinct cGMP-inhibited cyclic nucleotide phosphodiesterases in developingandmatureratbrain. Neuroscience 72, 567-578. doi: 10.1016/0306-4522(95)00520-X
68. Rico, B. (2012). Finding a druggable target for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 109, 11902-11903. doi: 10.1073/pnas.1209389109.
69. Riviere, J. B., Mirzaa, G. M., O'Roak, B. J., Beddaoui, M., Alcantara, D., Conway, R. L., et al. (2012). De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat. Genet. 44, 934-940. doi: 10.1038/ng.2331.
70. Rodrigues, G. A., Falasca, M., Zhang, Z., Ong, S. H., and Schlessinger, J. (2000). A novel positive feedback loop mediated by the docking protein Gab1 and phos-phatidylinositol 3-kinase in epidermal growth factor receptor signaling. Mol. Cell. Biol. 20, 1448-1459. doi: 10.1128/MCB.20.4.1448-1459.2000.
71. Rong, R., Ahn, J. Y., Huang, H., Nagata, E., Kalman, D., Kapp, J. A., et al. (2003). PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat. Neurosci. 6, 1153-1161. doi: 10.1038/nn1134.
72. Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554. doi: 10.1126/science.1096502.
73. Sanna, P. P., Cammalleri, M., Berton, F., Simpson, C., Lutjens, R., Bloom, F. E., et al. (2002). Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region. J. Neurosci. 22, 3359-3365.
74. Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-Dos-Santos, A. J., Stanford, W. L., Bolon, B., et al. (2000). Function of PI3Ky in thymocyte development, T cell activation, and neutrophil migration. Science 287, 1040-1046. doi: 10.1126/science.287.5455.1040.
75. Serajee, F. J., Nabi, R., Zhong, H., and Mahbubul Huq, A. H. M. (2003). Association of INPP1, PIK3CG, and TSC2 gene variants with autistic disorder: implications for phosphatidylinositol signalling in autism. J. Med. Genet. 40, e119. doi: 10.1136/jmg.40.11.e119.
76. Sharma, A., Hoeffer, C. A., Takayasu, Y., Miyawaki, T., Mcbride, S. M., Klann, E., et al. (2010). Dysregulation of mTORsignalingin fragileXsyndrome. J. Neurosci. 30, 694-702. doi: 10.1523/jneurosci.3696-09.2010.
77. Shepherd, P. R., and Denny, W. A. (2012). Beta-testing of PI3-kinase inhibitors: is betabetter? CancerDiscov. 2,393-394. doi: 10.1158/2159-8290.cd-12-0122.
78. Shioi, T., Kang, P. M., Douglas, P. S., Hampe, J., Yballe, C. M., Lawitts, J., et al. (2000). The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBOJ. 19,2537-2548. doi: 10.1093/emboj/19.11.2537.
79. Silberberg, G., Darvasi, A., Pinkas-Kramarski, R., and Navon, R. (2006). The involvement of ErbB4 with schizophrenia: association and expression studies. Am. J. Med. Genet. Part B Neuropsychiat. Genet. 141B, 142-148. doi: 10.1002/ajmg. b.30275
80. Sopasakis, V. R., Liu, P., Suzuki, R., Kondo, T., Winnay, J., Tran, T. T., et al. (2010). Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation. Cell Metab. 11, 220-230. doi: 10.1016/j.cmet.2010.02.002.
81. Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892. doi: 10.1086/342734.
82. Sui, L., Wang, J., and Li, B. M. (2008). Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathwayin long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learn. Mem. 15, 762-776. doi: 10.1101/lm.1067808.
83. Tsai, P. T., Hull, C., Chu, Y., Greene-Colozzi, E., Sadowski, A. R., Leech, J. M., et al. (2012). Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 488, 647-651. doi: 10.1038/nature11310.
84. Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Taka-hashi, H., et al. (2013). Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer a^ oligomer bound to cellular prion protein. Neuron 79, 887-902. doi: 10.1016/j.neuron.2013.06.036.
85. Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., and Bilanges, B. (2010). The emerging mechanisms of isoform-specific PI3K signalling. Nat. Rev. Mol. CellBiol. 11, 329-341. doi: 10.1038/nrm2882.
86. Veikkolainen, V., Vaparanta, K., Halkilahti, K., Iljin, K., Sundvall, M., and Elenius, K. (2011). Function of ERBB4 is determined by alternative splicing. Cell Cycle 10, 2647-2657. doi: 10.4161/cc.10.16.17194
87. Vullhorst, D., Neddens, J., Karavanova, I., Tricoire, L., Petralia, R. S., McBain, C. J., et al. (2009). Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus. J. Neurosci. 29, 12255-12264. doi: 10.1523/JNEUROSCI.2454-09.2009.
88. Waite, K., and Eickholt, B. J. (2010). The neurodevelopmental implications of PI3K signaling. Curr. Top. Microbiol. Immunol. 346, 245-265. doi: 10.1007/82_ 2010_82
89. Wang, H., and Doering, L. C. (2013). Reversing autism by targeting downstream mTOR signaling. Front. Cell. Neurosci. 7:28. doi: 10.3389/fncel.2013.00028.
90. Williams, S. C. P. (2012). Drugs targeting mGluR5 receptor offer "fragile" hope for autism. Nat. Med. 18, 840-840. doi: 10.1038/nm0612-840.
91. Yin, D. M., Sun, X. D., Bean, J. C., Lin, T. W., Sathyamurthy, A., Xiong, W. C., et al. (2013). Regulation of spine formation by ErbB4 in PV-positive interneurons. J. Neurosci. 33, 19295-19303. doi: 10.1523/JNEUROSCI.2090-13.2013.
92. Zhao, J. J., Liu, Z., Wang, L., Shin, E., Loda, M. F., and Roberts, T. M. (2005). The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 102, 18443-18448. doi: 10.1073/pnas.0508988102.
93. Zhao, L., and Vogt, P. K. (2008). Class I PI3K in oncogenic cellular transformation. Oncogene27, 5486-5496. doi: 10.1038/onc.2008.244.
94. Zhao, W.-Q., and Alkon, D. L. (2001). Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol. 177, 125-134. doi: 10.1016/S0303-7207(01)00455-5
95. Zheng, W., Wang, H., Zeng, Z., Lin, J., Little, P. J., Srivastava, L. K., et al. (2012). The possible role of the Akt signaling pathway in schizophrenia. Brain Res. 1470, 145-158. doi: 10.1016/j.brainres.2012.06.032
96. Zhou, J., and Parada, L. F. (2012). PTEN signaling in autism spectrum disorders. Curr. Opin. Neurobiol. 22, 873-879. doi: 10.1016/j.conb.2012.05.004